Gilead Sciences, Inc. (NASDAQ:GILD) is one of the 10 Best Cheap Stocks to Buy According to Billionaire Ray Dalio.

NMRA-861 has demonstrated a potentially best-in-class pharmacological profile and robust activity in preclinical efficacy models. NMRA-861 was safe and well-tolerated in pre-clinical toxicology ...

A systematic review of almost 50 randomized clinical trials brings some clarity to concerns about antidepressant withdrawal ...

Topline results from the CHASE trial expected by end of Q3 2025 -- -- Potential for CHASE to serve as a pivotal trial in support of a Biologics License Application (BLA) submission, contingent on ...

Early abdominal CT may be warranted among patients with unknown or uncertain biochemical screening results for primary aldosteronism.

The project aims to understand the impact of existing therapies as forms of intervention on hospital outcomes, as well as one-year clinical outcomes, and to use appropriate measures to prevent them.

Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic ...

ARO-C3 is an investigational RNA interference therapeutic designed to reduce liver production of complement component 3 as a potential therapy for various complement-mediated diseases.

Mysuru: Amid reports of a sudden spike in cardiac-related illnesses among younger patients, the Cardiological Society of ...

As patients increasingly turn to cannabis for chronic pain, clinicians grapple with mixed evidence and a lack of high-quality ...

The National Cancer Institute faces severe budget cuts, staff exodus, and halted research, threatening decades of progress ...

For the fifth consecutive year, Knowtion Health, a leading healthcare revenue cycle company offering deeper, broader, and smarter revenue recovery solutions to help providers get paid faster, with ...